US Executive Compensation Proxy SEC Filings — September 01, 2026
The three filings in this stream reveal a stark contrast in corporate governance and shareholder value events. The Roku-FOX merger (DEFM14A) is the dominant, high-materiality event, presenting a complex arbitrage opportunity with asymmetric termination fees and fixed exchange ratio risk. Acurx Pharmaceuticals' proxy is a routine, low-impact annual meeting with no material executive compensation or governance changes. Pacer Funds Trust's proposal for a 'manager-of-managers' structure is a moderate-materiality governance shift that could improve operational efficiency but reduces shareholder oversight. No period-over-period trends or insider activity were available in the enriched data for these filings, limiting trend analysis. The key actionable intelligence centers on the Roku-FOX merger dynamics and the Pacer Funds Trust governance vote.